Encinitas, CA, United States of America

Howard R Soule


Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 68(Granted Patents)


Company Filing History:


Years Active: 1996-2001

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Howard R Soule: Innovator in Blood Coagulation Research

Introduction

Howard R Soule is a notable inventor based in Encinitas, CA (US). He has made significant contributions to the field of blood coagulation through his innovative research and patented inventions. With a total of 3 patents, Soule's work focuses on developing monoclonal-type antibodies that target specific factors involved in coagulation.

Latest Patents

One of Howard R Soule's latest patents is centered on blood coagulation protein antagonists and their uses. This patent discloses coagulation protein antagonists, which include monoclonal-type antibodies and related cell lines. These antibodies are designed for the production of specific, neutralizing antibodies against factors VII and VIIa, as well as the tissue factor/factor VIIa bimolecular complex. The applications of these antibodies are vast, including their use in the prevention or treatment of thrombotic diseases, immunoaffinity isolation, and purification of coagulation factors, as well as determining these factors in biological samples.

Career Highlights

Throughout his career, Howard R Soule has worked with several companies, including Corvas International, Inc. and Corvas Inc. His experience in these organizations has allowed him to advance his research and contribute to the development of innovative solutions in the medical field.

Collaborations

One of his notable coworkers is Terence Kevin Brunck, with whom he has collaborated on various projects related to blood coagulation.

Conclusion

Howard R Soule's contributions to the field of blood coagulation through his patents and research have made a significant impact on medical science. His innovative work continues to pave the way for advancements in the prevention and treatment of thrombotic diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…